Dyne Therapeutics’ CMO Douglas Kerr Granted 8,000 RSUs and 12,000 Stock Options on October 20, 2026

view original post

On October 20, 2026, Kerr was granted 8,000 RSUs at no cost, vesting quarterly over four years starting January 20, 2027. Stock Option Award: Kerr recei …